Results: 43
Differential expression of miR-17~92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Epigenetics of myelodysplastic syndromes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Inherited genetic susceptibility to multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Very small embryonic-like stem cells (VSELs) represent a real challenge in stem cell biology: recent pros and cons in the midst of a lively debate.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 473, doi. 10.1038/leu.2013.255
- By:
- Publication type:
- Article
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
- Published in:
- 2014
- By:
- Publication type:
- journal article
KRas(G12D)-evoked leukemogenesis does not require β-catenin.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.
- Published in:
- 2014
- By:
- Publication type:
- journal article
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 589, doi. 10.1038/leu.2013.342
- By:
- Publication type:
- Article
CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 609, doi. 10.1038/leu.2013.354
- By:
- Publication type:
- Article
Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 716, doi. 10.1038/leu.2013.347
- By:
- Publication type:
- Article
Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 577, doi. 10.1038/leu.2013.264
- By:
- Publication type:
- Article
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 680, doi. 10.1038/leu.2013.231
- By:
- Publication type:
- Article
Cyclin D1 splice site variant triggers chromosomal aberrations in healthy humans.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 721, doi. 10.1038/leu.2013.353
- By:
- Publication type:
- Article
Inherited genetic susceptibility to multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 518, doi. 10.1038/leu.2013.344
- By:
- Publication type:
- Article
Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 713, doi. 10.1038/leu.2013.341
- By:
- Publication type:
- Article
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 649, doi. 10.1038/leu.2013.358
- By:
- Publication type:
- Article
Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 694, doi. 10.1038/leu.2013.322
- By:
- Publication type:
- Article
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34<sup>+</sup> hemopoietic progenitors cells.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 705, doi. 10.1038/leu.2013.331
- By:
- Publication type:
- Article
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 658, doi. 10.1038/leu.2013.253
- By:
- Publication type:
- Article
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 525, doi. 10.1038/leu.2013.350
- By:
- Publication type:
- Article
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 621, doi. 10.1038/leu.2013.330
- By:
- Publication type:
- Article
Differential expression of miR-17∼92 identifies BCL2 as a therapeutic target in BCR-ABL-positive B-lineage acute lymphoblastic leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 554, doi. 10.1038/leu.2013.361
- By:
- Publication type:
- Article
Elevated PTPN2 expression is associated with inferior molecular response in de-novo chronic myeloid leukaemia patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 702, doi. 10.1038/leu.2013.329
- By:
- Publication type:
- Article
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 719, doi. 10.1038/leu.2013.348
- By:
- Publication type:
- Article
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 726, doi. 10.1038/leu.2013.352
- By:
- Publication type:
- Article
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 710, doi. 10.1038/leu.2013.333
- By:
- Publication type:
- Article
Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 666, doi. 10.1038/leu.2013.346
- By:
- Publication type:
- Article
Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 708, doi. 10.1038/leu.2013.332
- By:
- Publication type:
- Article
PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 629, doi. 10.1038/leu.2013.351
- By:
- Publication type:
- Article
CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 566, doi. 10.1038/leu.2013.201
- By:
- Publication type:
- Article
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 485, doi. 10.1038/leu.2013.337
- By:
- Publication type:
- Article
Blocking ETV6/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 600, doi. 10.1038/leu.2013.345
- By:
- Publication type:
- Article
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 675, doi. 10.1038/leu.2013.225
- By:
- Publication type:
- Article
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signaling.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 543, doi. 10.1038/leu.2013.349
- By:
- Publication type:
- Article
Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 507, doi. 10.1038/leu.2013.311
- By:
- Publication type:
- Article
Epigenetics of myelodysplastic syndromes.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 497, doi. 10.1038/leu.2013.343
- By:
- Publication type:
- Article
Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 696, doi. 10.1038/leu.2013.325
- By:
- Publication type:
- Article
Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 642, doi. 10.1038/leu.2013.334
- By:
- Publication type:
- Article
Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 690, doi. 10.1038/leu.2013.335
- By:
- Publication type:
- Article
Impact of the revised International Prognostic Scoring System on the outcome of patients with acute myeloid leukemia with or without antecedent myelodysplastic syndrome.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 723, doi. 10.1038/leu.2013.356
- By:
- Publication type:
- Article
KRas<sup>G12D</sup>-evoked leukemogenesis does not require β-catenin.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 698, doi. 10.1038/leu.2013.328
- By:
- Publication type:
- Article